Objectives: We developed a registry guidance to provide a standard for data collection, analysis and methodical management of information on the influence of drug exposure on pregnant women and fetus. Methods: We surveyed guidances and regulations of clinical trials and the pharmaceutical affairs law, compared them with Pregnancy Exposure Registry of other countries and in addition, investigated related references. We found the flaws of the present registry and supplemented it based on better results from other countries. Results: We developed a concrete and detailed report that included pregnancy drug exposure cases necessary for close monitoring, types and characteristics of data on pregnancy drug exposure, the requirements of registry data, and essential items needed to be researched. Conclusions: Information on pregnancy drug exposure in Korea can be effectively collected by using this report which provides a comprehensive assess to drug’s influence on pregnant women and fetus, and in addition, accurate information about safety and effectiveness of drug use in pregnant women and fetus can be obtained by sharing data globally and managing it synthetically and systematically
목차
Abstract 연구내용 및 방법 연구내용 연구 방법 연구결과(Results) 보고서 형식 고찰(Discussion) 및 결론 감사의 말씀 참고문헌
키워드
registry guidancepregnant womendrug exposure
저자
김수희 [ Soohee Kim | 숙명여자대학교 임상약학대학원 ]
노혜진 [ Hyejin Noh | 서울대학교 약학대학 ]
지은희 [ Eun-hee Ji | 서울대학교 약학대학 ]
윤정현 [ Jeong-Hyun Yoon | 부산대학교 약학대학 ]
김경임 [ Kyung Im Kim | 서울대학교 약학대학 ]
신완균 [ Wan Gyoon Shin | 서울대학교 약학대학, 서울대학교 종합약학연구소 ]